Accepted for/Published in: Journal of Medical Internet Research
Date Submitted: May 28, 2020
Date Accepted: Oct 26, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Pharmacists’ Perceptions of the Benefits and Challenges of Electronic Product Information System Implementation in Hong Kong: A Qualitative Study
ABSTRACT
Background:
With the advancement of technology, more countries are now adopting the use of electronic product inserts (ePI), which refer to an electronic version of physical product inserts in a semi-structured format optimized for electronic manipulation. The successful implementation of ePI has led to advantages and convenience to patients, healthcare professionals, and pharmaceutical companies in many regions and countries. In the Hong Kong Special Administrative Region (SAR), there is currently no citywide implementation of ePI. The SAR exhibits conditions that would favor the implementation of an ePI system, as well as existing barriers hindering its implementation. However, no study has been performed to examine the specific situation in Hong Kong.
Objective:
The objective of this study is to explore working pharmacists’ overall perception of ePI and to identify potential challenges to the implementation of an ePI system in Hong Kong.
Methods:
This qualitative study involved structured interviews with practicing pharmacists in Hong Kong. Pharmacists were eligible if they were (1) licensed to practice in Hong Kong, (2) self-identified as capable of reading and writing in English, and (3) currently working locally in any pharmacy-related sectors and institutions. A structured interview was conducted to gather respondents’ perceived advantages of ePI over paper PI in different aspects, such as professionalism, usability, presentation and environment, as well as challenges of citywide ePI implementation in Hong Kong. Thematic analysis was adopted to analyze the qualitative data. Grounded theory was used to generate an explanation and identify specific outcomes.
Results:
Sixteen pharmacists were recruited, comprising four community pharmacists, five hospital pharmacists and seven industrial pharmacists. All of them used electronic platforms at least once per month on average. Respondents identified many flaws in physical package inserts that can potentially be mitigated using ePI. The speed with which drug information can be retrieved and the degree to which the drug information is up-to-date were considered the greatest strengths of ePI. The clarity with which ePI presents drug information to patients was considered as the weakest aspect of ePI. Many respondents highlighted concerns about the security risks and high cost associated with system maintenance and that certain subpopulations may not be sufficiently computer-literate to navigate the ePI system. Respondents also voiced many concerns about the implementation and maintenance of a local ePI system.
Conclusions:
We conclude that ePI system is generally supported by pharmacists but concerns about implementation process and maintenance of the system has been raised. The perceived benefits of ePI gathered from this study, as well as collective evidence from other countries with mature ePI systems, confirm that more efforts should be made to promote optimized development and implementation of an ePI system in Hong Kong.
Citation
The author of this paper has made a PDF available, but requires the user to login, or create an account.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.